INNT – $1,000 Short Swing

Shorting INNT (Innovative Biopharmaceuticals) on the backside of their pumped-up chart.

Their $40M At-The-Money dilution and looming $135M shelf offering are killing both the stock’s price and their investor’s trust.

Leave a Reply

Your email address will not be published.